Press Releases
CPhI report predicts new finished product manufacturing hub in...
A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. ...
Press Releases
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference...
Press Releases
Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. ...
Press Releases
Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at...
Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at...
Press Releases
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic...
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal...
Press Releases
Cleveland Clinic and Brooks Automation Announce New Biobanking Facility
Cleveland Clinic and Brooks Automation. Inc. willlaunch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of human tissue samples and advance personalized...
Press Releases
UCB announces BRIVIACT now approved by FDA to treat...
UCB announced that the U.S. FDA has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug BRIVIACT CV oral formulations indicated...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.